230 related articles for article (PubMed ID: 28371753)
1. A microfluidic platform for drug screening in a 3D cancer microenvironment.
Pandya HJ; Dhingra K; Prabhakar D; Chandrasekar V; Natarajan SK; Vasan AS; Kulkarni A; Shafiee H
Biosens Bioelectron; 2017 Aug; 94():632-642. PubMed ID: 28371753
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic chip with integrated electrical cell-impedance sensing for monitoring single cancer cell migration in three-dimensional matrixes.
Nguyen TA; Yin TI; Reyes D; Urban GA
Anal Chem; 2013 Nov; 85(22):11068-76. PubMed ID: 24117341
[TBL] [Abstract][Full Text] [Related]
3. Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment.
Mitxelena-Iribarren O; Zabalo J; Arana S; Mujika M
Biosens Bioelectron; 2019 Jan; 123():237-243. PubMed ID: 30224287
[TBL] [Abstract][Full Text] [Related]
4. Near-physiological microenvironment simulation on chip to evaluate drug resistance of different loci in tumour mass.
Wang S; Mao S; Li M; Li HF; Lin JM
Talanta; 2019 Jan; 191():67-73. PubMed ID: 30262100
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic Biosensor-Based Devices for Rapid Diagnosis and Effective Anti-cancer Therapeutic Monitoring for Breast Cancer Metastasis.
Sukanya VS; Rath SN
Adv Exp Med Biol; 2022; 1379():319-339. PubMed ID: 35760998
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic 3D models of cancer.
Sung KE; Beebe DJ
Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
[TBL] [Abstract][Full Text] [Related]
7. A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems.
Tang Y; Soroush F; Sheffield JB; Wang B; Prabhakarpandian B; Kiani MF
Sci Rep; 2017 Aug; 7(1):9359. PubMed ID: 28839211
[TBL] [Abstract][Full Text] [Related]
8. Digital microfluidics with impedance sensing for integrated cell culture and analysis.
Shih SC; Barbulovic-Nad I; Yang X; Fobel R; Wheeler AR
Biosens Bioelectron; 2013 Apr; 42():314-20. PubMed ID: 23208104
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures.
Dornhof J; Kieninger J; Muralidharan H; Maurer J; Urban GA; Weltin A
Lab Chip; 2022 Jan; 22(2):225-239. PubMed ID: 34851349
[TBL] [Abstract][Full Text] [Related]
10. [Microfluidic cell culture array chip for drug screening assays].
Zheng Y; Wu J; Shao J; Jin Q; Zhao J
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):779-85. PubMed ID: 19670650
[TBL] [Abstract][Full Text] [Related]
11. A human liver microphysiology platform for investigating physiology, drug safety, and disease models.
Vernetti LA; Senutovitch N; Boltz R; DeBiasio R; Shun TY; Gough A; Taylor DL
Exp Biol Med (Maywood); 2016 Jan; 241(1):101-14. PubMed ID: 26202373
[TBL] [Abstract][Full Text] [Related]
12. The impact of tumor stroma on drug response in breast cancer.
Dittmer J; Leyh B
Semin Cancer Biol; 2015 Apr; 31():3-15. PubMed ID: 24912116
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform).
Park D; Son K; Hwang Y; Ko J; Lee Y; Doh J; Jeon NL
Front Immunol; 2019; 10():1133. PubMed ID: 31191524
[TBL] [Abstract][Full Text] [Related]
14. Vascularized microfluidic platforms to mimic the tumor microenvironment.
Michna R; Gadde M; Ozkan A; DeWitt M; Rylander M
Biotechnol Bioeng; 2018 Nov; 115(11):2793-2806. PubMed ID: 29940072
[TBL] [Abstract][Full Text] [Related]
15. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
16. Multilayer architecture microfluidic network array for combinatorial drug testing on 3D-cultured cells.
Chang HC; Lin CH; Juang D; Wu HW; Lee CY; Chen C; Hsu CH
Biofabrication; 2019 Jun; 11(3):035024. PubMed ID: 31051482
[TBL] [Abstract][Full Text] [Related]
17. Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
Bruce A; Evans R; Mezan R; Shi L; Moses BS; Martin KH; Gibson LF; Yang Y
PLoS One; 2015; 10(10):e0140506. PubMed ID: 26488876
[TBL] [Abstract][Full Text] [Related]
18. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
Lei KF; Wu MH; Hsu CW; Chen YD
Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a microfluidic model of the tumour microenvironment.
Ayuso JM; Virumbrales-Muñoz M; Lacueva A; Lanuza PM; Checa-Chavarria E; Botella P; Fernández E; Doblare M; Allison SJ; Phillips RM; Pardo J; Fernandez LJ; Ochoa I
Sci Rep; 2016 Oct; 6():36086. PubMed ID: 27796335
[TBL] [Abstract][Full Text] [Related]
20. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
